UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Delirium affects length of hospital stay after lung transplantation

Journal of critical care, 2015-02, Vol.30 (1), p.126-129

2015

Volltextzugriff (PDF)

OP0174 SUBCLINICAL INTERSTITIAL LUNG DISEASE IS FREQUENT AND PROGRESSES ACROSS DIFFERENT CONNECTIVE TISSUE DISEASES

Annals of the rheumatic diseases, 2021-06, Vol.80 (Suppl 1), p.104-105

2021

Volltextzugriff (PDF)

Depression, Quality of Life, and Mortality Early Following Lung Transplantation

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S227-S228

2016

Volltextzugriff (PDF)

A National Survey of Practice and Perceptions Regarding Anti-Fibrotic Medication in Lung Transplant Recipients

The Journal of heart and lung transplantation, 2016-04, Vol.35 (4), p.S226-S227

2016

Volltextzugriff (PDF)

POS0413-HPR EXERCISE CAPACITY BY THE 6MWD IN A PROSPECTIVE RMD-ILD COHORT FOLLOWED OVER 12 MONTHS; IMPACT OF DISEASE CHARACTERISTICS AND PATIENT REPORTED MEASURES

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.501-502

2024

Volltextzugriff (PDF)

OP0252 ONE-YEAR TRAJECTORIES OF DIFFUSION CAPACITY OF CARBON MONOXIDE AS POTENTIAL MARKERS OF OUTCOME IN SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY HYPERTENSION

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.164-165

2024

Volltextzugriff (PDF)

POS0870 PATIENTS WITH SYSTEMIC SCLEROSIS HAVE IMPAIRED FORCED VITAL CAPACITY, EVEN IN THE ABSENCE OF INTERSTITIAL LUNG DISEASE

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.729-730

2022

Volltextzugriff (PDF)

AB0686 ACUTE RESPIRATORY WORSENING IN RMD-ILD IS ASSOCIATED WITH INCREASED RISK OF DEATH AND LUNG TRANSPLANTATION

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.1630-1631

2024

Volltextzugriff (PDF)

OP0068 INTERSTITIAL LUNG DISEASE IS FREQUENTLY PROGRESSIVE IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.127-128

2024

Volltextzugriff (PDF)

POS0220 MILDER ILD WITH PRESERVED LUNG FUNCTION SIGNIFICANTLY CONTRIBUTES TO RESPIRATORY CAUSED MORTALITY IN SSc

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.334-335

2024

Volltextzugriff (PDF)

POS0065 INTERSTITIAL LUNG DISEASE ASSOCIATED WITH PRIMARY SJÖGREN’S SYNDROME IS FREQUENTLY PROGRESSIVE

Annals of the rheumatic diseases, 2022-06, Vol.81 (Suppl 1), p.249-249

2022

Volltextzugriff (PDF)

OP0236 RISK FACTORS FOR SSc-ILD PROGRESSION USING THE NEW PPF GUIDELINE AND INBUILD PF-ILD CRITERIA

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.156-157

2023

Volltextzugriff (PDF)

POS1291 PREDICTION OF MORTALITY IN SSC-ILD DEPENDS ON DEFINITION OF ILD PROGRESSION

Annals of the rheumatic diseases, 2023-06, Vol.82 (Suppl 1), p.992-993

2023

Volltextzugriff (PDF)

OP0100 PREDICTION OF STABLE SSc-ILD DEPENDS ON DEFINITION OF ILD PROGRESSION

Annals of the rheumatic diseases, 2024-06, Vol.83 (Suppl 1), p.72-73

2024

Volltextzugriff (PDF)

THU0331 INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: DECLINE IN FORCED VITAL CAPACITY DOES NOT PREDICT FURTHER PROGRESSION IN THE FOLLOWING PERIOD

Annals of the rheumatic diseases, 2020-06, Vol.79 (Suppl 1), p.396-396

2020

Volltextzugriff (PDF)

A102 TRANSPLANTATION: ADVANCES AND CHALLENGES: Changes In Dyspnea Following Lung Transplantation: A Pooled Cohort Study

American journal of respiratory and critical care medicine, 2017-01, Vol.195

2017

Volltextzugriff (PDF)

Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real‐world multicentre cohort

Respirology (Carlton, Vic.), 2021-10, Vol.26 (10), p.982-988

2021

Volltextzugriff (PDF)

(400) - A Nordic Multicenter Study on Size Mismatch in Bilateral Lung Transplantation

The Journal of heart and lung transplantation, 2018-04, Vol.37 (4), p.S166-S166

2018

Volltextzugriff (PDF)

D104 THAT MEANS A LOT: SIGNIFICANCE OF COPD COMORBIDITIES: Chronic Obstructive Pulmonary Disease Is Associated With Increased Risk Of Mortality Among Patients With Atrial Fibrillation: Insights From The Aristotle Trial

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

D23 SYMPTOMS MATTER: COUGH, DYSPNEA, FATIGUE AND QUALITY OF LIFE: Disease Severity And Quality Of Life In Newly Diagnosed Idiopathic Pulmonary Fibrosis Patients

American journal of respiratory and critical care medicine, 2016-01, Vol.193, p.1

2016

Volltextzugriff (PDF)

C30 LATE BREAKING ABSTRACTS IN DISEASE TREATMENT AND CLINICAL OUTCOMES: Physical Function As Measured By 6-Minute Walk Distance Or Accelerometry Predicts Clinical Outcomes In COPD Patients Independent Of Gold 2011

American journal of respiratory and critical care medicine, 2014-01, Vol.189, p.1

2014

Volltextzugriff (PDF)

B22 THAT'LL BE THE DAY: UNDERSTANDING IPF RISK FACTORS AND OUTCOMES: Associations Between Hospitalization And Forced Vital Capacity Endpoints And Survival In Idiopathic Pulmonary Fibrosis

American journal of respiratory and critical care medicine, 2015-01, Vol.191, p.1

2015

Volltextzugriff (PDF)

Mortality and Respiratory Failure After Thoracoscopic Lung Biopsy for Interstitial Lung Disease

The Annals of thoracic surgery, 2017-08, Vol.104 (2), p.465-470

2017

Volltextzugriff (PDF)

Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials

The lancet respiratory medicine, 2015-05, Vol.3 (5), p.388-396

2015

Volltextzugriff (PDF)

Newly Diagnosed IPF at Tertiary Care Pulmonary Centers: Initial Results From the Idiopathic Pulmonary Fibrosis — PROspective Outcomes (IPF-PRO) Registry

Chest, 2015-10, Vol.148 (4), p.362A-362B

2015

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(52)
Mit Volltextzugriff
(35)

Publikationsform

Artikel
(52)

Sprache

Englisch
(51)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Delirium affects length of hospital stay after lung transplantation

OP0174 SUBCLINICAL INTERSTITIAL LUNG DISEASE IS FREQUENT AND PROGRESSES ACROSS DIFFERENT CONNECTIVE TISSUE DISEASES

Depression, Quality of Life, and Mortality Early Following Lung Transplantation

A National Survey of Practice and Perceptions Regarding Anti-Fibrotic Medication in Lung Transplant Recipients

POS0413-HPR EXERCISE CAPACITY BY THE 6MWD IN A PROSPECTIVE RMD-ILD COHORT FOLLOWED OVER 12 MONTHS; IMPACT OF DISEASE CHARACTERISTICS AND PATIENT REPORTED MEASURES

OP0252 ONE-YEAR TRAJECTORIES OF DIFFUSION CAPACITY OF CARBON MONOXIDE AS POTENTIAL MARKERS OF OUTCOME IN SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY HYPERTENSION

POS0870 PATIENTS WITH SYSTEMIC SCLEROSIS HAVE IMPAIRED FORCED VITAL CAPACITY, EVEN IN THE ABSENCE OF INTERSTITIAL LUNG DISEASE

AB0686 ACUTE RESPIRATORY WORSENING IN RMD-ILD IS ASSOCIATED WITH INCREASED RISK OF DEATH AND LUNG TRANSPLANTATION

OP0068 INTERSTITIAL LUNG DISEASE IS FREQUENTLY PROGRESSIVE IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME

POS0220 MILDER ILD WITH PRESERVED LUNG FUNCTION SIGNIFICANTLY CONTRIBUTES TO RESPIRATORY CAUSED MORTALITY IN SSc

POS0065 INTERSTITIAL LUNG DISEASE ASSOCIATED WITH PRIMARY SJÖGREN’S SYNDROME IS FREQUENTLY PROGRESSIVE

OP0236 RISK FACTORS FOR SSc-ILD PROGRESSION USING THE NEW PPF GUIDELINE AND INBUILD PF-ILD CRITERIA

POS1291 PREDICTION OF MORTALITY IN SSC-ILD DEPENDS ON DEFINITION OF ILD PROGRESSION

OP0100 PREDICTION OF STABLE SSc-ILD DEPENDS ON DEFINITION OF ILD PROGRESSION

THU0331 INTERSTITIAL LUNG DISEASE IN SYSTEMIC SCLEROSIS: DECLINE IN FORCED VITAL CAPACITY DOES NOT PREDICT FURTHER PROGRESSION IN THE FOLLOWING PERIOD

A102 TRANSPLANTATION: ADVANCES AND CHALLENGES: Changes In Dyspnea Following Lung Transplantation: A Pooled Cohort Study

Outcomes of patients with advanced idiopathic pulmonary fibrosis treated with nintedanib or pirfenidone in a real‐world multicentre cohort

(400) - A Nordic Multicenter Study on Size Mismatch in Bilateral Lung Transplantation

D104 THAT MEANS A LOT: SIGNIFICANCE OF COPD COMORBIDITIES: Chronic Obstructive Pulmonary Disease Is Associated With Increased Risk Of Mortality Among Patients With Atrial Fibrillation: Insights From The Aristotle Trial

D23 SYMPTOMS MATTER: COUGH, DYSPNEA, FATIGUE AND QUALITY OF LIFE: Disease Severity And Quality Of Life In Newly Diagnosed Idiopathic Pulmonary Fibrosis Patients

C30 LATE BREAKING ABSTRACTS IN DISEASE TREATMENT AND CLINICAL OUTCOMES: Physical Function As Measured By 6-Minute Walk Distance Or Accelerometry Predicts Clinical Outcomes In COPD Patients Independent Of Gold 2011

B22 THAT'LL BE THE DAY: UNDERSTANDING IPF RISK FACTORS AND OUTCOMES: Associations Between Hospitalization And Forced Vital Capacity Endpoints And Survival In Idiopathic Pulmonary Fibrosis

Mortality and Respiratory Failure After Thoracoscopic Lung Biopsy for Interstitial Lung Disease

Association of hospital admission and forced vital capacity endpoints with survival in patients with idiopathic pulmonary fibrosis: analysis of a pooled cohort from three clinical trials

Newly Diagnosed IPF at Tertiary Care Pulmonary Centers: Initial Results From the Idiopathic Pulmonary Fibrosis — PROspective Outcomes (IPF-PRO) Registry

Suchergebnisse filtern